Gary J Doherty (Gary Doherty)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

JCO precision oncology

British journal of cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

James F Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca S Kristeleit, Rowan E Miller, Gareth J Veal, Christopher J Corrigan, Stephen J Till, Alessandro Massimo Gianni, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary J Doherty, Hannah J Gould, Giulia Pellizzari, Mano Nakamura, Kristina M Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah E Pinder, Heather J Bax, Debra H Josephs, Sophia N Karagiannis
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature communications 14 (1) (2023)
Trevor J Pugh, Jonathan L Bell, Jeffrey P Bruce, Gary J Doherty, Matthew R Galvin, Michelle F Green, Haley Hunter-Zinck, Priti Kumari, Michele L LeNoue-Newton, Marilyn M Li, James R Lindsay, Tali Mazor, Andrea Ovalle, Stephen-John Sammut, Nikolaus Schultz, Thomas V Yu, Shawn M Sweeney, Brady Bernard, null null
AACR Project GENIE: 100,000 Cases and Beyond. Cancer discovery 12 (9) (2022)
Gary J Doherty, Mehmet Goksu, Bruno Henrique Rala de Paula
Rethinking cancer clinical trials for COVID-19 and beyond. Nature cancer 1 (6) (2022)
Rosalind Kieran, Bruno Henrique Rala de Paula, Michael Hubank, Allanah Barker, Anna L Paterson, David Gilligan, Gary J Doherty
Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat. JCO precision oncology 5 (2022)
Gary J Doherty, Bruno H R de Paula
Cannabinoids in glioblastoma multiforme-hype or hope? British journal of cancer 124 (8) (2021)
Gary J Doherty, Mehmet Goksu, Bruno Henrique Rala de Paula
Rethinking cancer clinical trials for COVID-19 and beyond. Nature cancer (2020)